Molecular-genetic bases of development of acute pancreatitis

Abstract

Acute pancreatitis is included into the three most common diseases of organs of the abdominal cavity following acute appendicitis and cholecystitis, with the middle share in this group of 10-16%. As before, acute pancreatitis is characterized by high morbidity and mortality. Many researchers confirm growth of severe forms of the disease with destructive changes in the pancreas.

Aim. A review of literature sources devoted to study of etiology, pathogenesis, classification, diagnosis and molecular-genetic bases of acute pancreatitis. Factors that play a role in development of the disease (episodes of infringement of the diet, cholelithiasis, vascular diseases, abuse of alcohol) are elucidated. Mechanisms of development of acute pancreatitis depending on the etiology, are described in detail, modern classification of acute pancreatitis is given. The main methods of diagnosis of the disease including both laboratory and instrumental ones, are described. Data of the methods of determination of severity of patients’ state based on evaluation of all the most important physiological systems, are presented. In terms of modern understanding of mechanisms of development of acute pancreatitis, the results of investigation of the probability for genetic predisposition to the studied disease are given that opens the ways for optimization of therapy and diagnosis. The results of both individual and large-scale genetic studies of acute pancreatitis are described. Research works with isolation of certain candidate genes whose protein products participate in the pathogenesis of acute pancreatitis, are presented.

Conclusion. A complex approach to diagnosis of acute pancreatitis with identification of different mutations in the studied genes, and also determination of the influence of epigenetic phenomena in the individuals of risk groups will permit to improve the results of the prophylactic, diagnostic and therapeutic activity in acute pancreatitis.

Keywords

acute pancreatitis / etiology / genes / pathogenesis

References

[1] Skutova VA, Danilov AI, Feoktistova ZhA. Acute pancreatitis: current problems in the diagnosis and complex treatment. Vestnik of the Smolensk State Medical Academy. 2016;15(2):78-84. (In Russ).

[2] Скутова В.А., Данилов А.И., Феоктистова Ж.А. Острый панкреатит: Актуальные вопросы диагностики и комплексного лечения // Вестник Смоленской государственной медицинской академии. 2016. Т. 15, №2. С. 78-84.

[3] Rakhimov RR. Complex approach to diagnostics and management of infected pancreatonecrosis. Permskiy Meditsinskiy Zhurnal. 2016;33(6):36-41. (In Russ).

[4] Рахимов Р.Р. Комплексный подход к диагностике и лечению инфицированного панкреонекроза // Пермский медицинский журнал. 2016. Т. 33, №6. С. 36-41.

[5] Rosendahl J, Kirsten H, Hegyi E, et al. Genome-wide association study identifies inversion in the CTRB1-CTRB2 locus to modify risk for alcoholic and non-alcoholic chronic pancreatitis. Gut. 2018; 67(10):1855-63. doi:10.1136/gutjnl-2017-314454

[6] Rosendahl J., Kirsten H., Hegyi E., et al. Genomewide association study identifies inversion in the CTRB1-CTRB2 locus to modify risk for alcoholic and nonalcoholic chronic pancreatitis // Gut. 2018. Vol. 67, №10. P. 1855-1863. doi:10.1136/gutjnl-2017-314454

[7] Baymuradov ShE. Infected pancreonecrosis as an issue of modern pancreatology. Vestnik Ekstrennoy Meditsiny. 2016;9(1):102-6. (In Russ).

[8] Баймурадов Ш.Э. Инфицированный панкреонекроз как проблема современной панкреатологии // Вестник экстренной медицины. 2016. Т. 9, №1. С. 102-106.

[9] Feng YC, Wang M, Zhu F, et al. Study on acute recent stage pancreatitis. World Journal of Gastroenterology. 2014;20(43):16138-45. doi:10.3748/wjg.v20.i43.16138

[10] Feng Y.C., Wang M., Zhu F., et al. Study on acute recent stage pancreatitis // World Journal of Gastroenterology. 2014. Vol. 20, №43. Р. 16138-16145. doi:10.3748/wjg.v20.i43.16138

[11] Vinnik YuS, Pervova OV, Cherdancev DV, et al. Influence of the genetic factors on the risk of the disease and characteristics of the course of the acute alcohol pancreatitis. Journal of Experimental and Clinical Surgery. 2010;3(4):317-22. (In Russ).

[12] Винник Ю.С., Первова О.В., Черданцев Д.В., и др. Влияние генетических факторов на риск возникновения и особенности течения острого алкогольного панкреатита // Вестник экспериментальной и клинической хирургии. 2010. Т. 3, №4. С. 317-322.

[13] Vlasov AP, Trofimov VA, Al-Kubaisi Sh-AS, et al. Risk factors of progression of acute pancreatitis Modern Problems of Science and Education. 2018; (5). Available at: http://www.science-education.ru/ru/article/view?id=28045. Accessed: 2020 February 29. (In Russ).

[14] Власов А.П., Трофимов В.А., Аль-Кубайси Ш.С., и др. Факторы прогрессирования острого панкреатита // Современные проблемы науки и образования. 2018. №5. Доступно по: http://www.science-education.ru/ru/article/view?id=28045. Ссылка активна на 29 февраля 2020.

[15] Yadav D, Hawes RH, Brand RE, et al. Alcohol consumption, cigarette smoking, and the risk of

[16] Yadav D., Hawes R.H., Brand R.E., et al. Alcohol consumption, cigarette smoking, and the risk of recurrent acute and chronic pancreatitis // Archives of Internal Medicine. 2009. Vol. 169, №11. Р. 1035-1045. doi:10.1001/archinternmed.2009.125

[17] recurrent acute and chronic pancreatitis. Archives

[18] Назаров В.Е., Спирин А.Н. Индивидуализированная антисекреторная и полиферментная терапия острого панкреатита легкой степени // Consillum Medicum. 2017. Т. 19, №8.1: Гастроэнтерология. С. 28-34.

[19] of Internal Medicine. 2009;169(11):1035-45. doi:10.1001/archinternmed.2009.125

[20] Тимербулатов М.В., Сендерович Е.И., Рахимов Р.Р., и др. Комплексный подход к лечению острого панкреатита // Медицинский вестник Башкортостана. 2013. Т. 8, №6. С. 100-102.

[21] Nazarov VE, Spirin AN. Individualized antisecretory and polyenzyme therapy of mild acute pancreatitis. Consillum Medicum. 2017;19(8.1: Gastroenterology):28-34. (In Russ).

[22] Aranovich D., Zilbermints V., Goldberg N., et al. Detection of Common Bile Duct Stones in Mild Acute Biliary Pancreatitis Using Magnetic Resonance Cholangiopancreatography // Surgery Research and Practice. 2018. Vol. 2018. P. 5216089. Доступно по: https://www.hindawi.com/journals/srp/2018/5216089. Ссылка активна на 7 июля 2020. doi:10.1155/2018/5216089

[23] Timerbulatov MV, Senderovich EI, Rakhimov RR, et al. Comprehensive approach to the treatment of acute pancreatitis. Meditsinskiy Vestnik Bashkortostana. 2013;8(6):100-2. (In Russ).

[24] Aksoy F., Demiral G., Ekinci Ö. Can the timing of laparoscopic cholecystectomy after biliary pancreatitis change the conversion rate to open surgery? // Asian Journal of Surgery. 2017. Vol. 41, №4. Р. 307-312. doi:10.1016/j.asjsur.2017.02.001

[25] Aranovich D, Zilbermints V, Goldberg N, et al. Detection of Common Bile Duct Stones in Mild Acute Biliary Pancreatitis Using Magnetic Resonance Cholangiopancreatography. Surgery Research and Practice. 2018;2018:5216089. Available at: https://www.hindawi.com/journals/srp/2018/5216089. Accessed: 2020 July 7. doi:10.1155/2018/5216089

[26] Lee S.L., Kim H.K., Choi H.H., et al. Diagnostic value of magnetic resonance cholangiopancreatography to detect bile duct stones in acute biliary pancreatitis // Pancreatology. 2018. Vol. 18, №1. P. 22-28. doi:10.1016/j.pan.2017.12.004

[27] Aksoy F, Demiral G, Ekinci Ö. Can the timing of laparoscopic cholecystectomy after biliary pancreatitis change the conversion rate to open surgery? Asian Journal of Surgery. 2017;41(4):307-12. doi:10.1016/j.asjsur.2017.02.001

[28] Nieratschker V., Batra A., Fallgatter A.J. Genetics and epigenetics of alcohol dependence // Journal of Molecular Psychiatry. 2013. №1. P. 11. doi:10.1186/2049-9256-1-11

[29] Lee SL, Kim HK, Choi HH, et al. Diagnostic value of magnetic resonance cholangiopancreatography to detect bile duct stones in acute biliary pancreatitis. Pancreatology. 2018;18(1):22-8. doi:10.1016/j.pan.2017.12.004

[30] Banks P.A., Bollen T.L., Dervenis C., et al. Classification of acute pancreatitis - 2012: revision of the Atlanta classification and definitions by international consensus // Gut. 2013. Vol. 62, №1. P. 102-111. doi:10.1136/gutjnl-2012-302779

[31] Nieratschker V, Batra A, Fallgatter A. Genetics and epigenetics of alcohol dependence. Journal of Molecular Psychiatry. 2013;(1):11. doi:10.1186/2049-9256-1-11

[32] Чернов В.Н., Белик Б.М., Алибекова А.З. Выбор тактики лечения больных с деструктивными формами острого панкреатита с применением прокальцитонинового теста // Кубанский научный медицинский вестник. 2014. №1. С. 176-178.

[33] Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis - 2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62(1):102-11. doi:10.1136/gutjnl-2012-302779

[34] Парфенов И.П., Белоусов В.А., Ярош А.Л., и др. Современные представления о роли цитокинов в патогенезе острого панкреатита // Научные ведомости БелГУ. Серия: Медицина. Фармация. 2011. №16. С. 40-45.

[35] Chernov VN, Belik BM, Alibekov AZ. Choice of tactics of treatment of patients with destructive forms of acute pancreatitis with the use of procalcitonin test. Kuban Scientific Medical Bulletin. 2014;(1):176-8. (In Russ).

[36] Dianliang Z., Jieshou L., Zhiwei J., et al. Association of plasma levels of tumor necrosis factor (TNF) α and its soluble receptors, two polymorphisms of the TNF gene, with acute severe pancreatitis and early septic shock due to it // Pancreas. 2003. Vol. 26, №4. С. 339-343. doi:10.1097/00006676-200305000-00005

[37] Parfenov IP, Belousov VA, Yarosh AL, et al. The contemporary view on cytokines role in the pathogenesis of acute pancreatitis. Belgorod State University Scientific Bulletin. Medicine. Pharmacy. 2011;(16):40-4. (In Russ).

[38] Powell J.J., Fearon K.C., Siriwardena A.K., et al. Evidence against a role for polymorphisms at tumor necrosis factor, interleukin-1 and interleukin-1 receptor antagonist gene loci in the regulation of disease severity in acute pancreatitis // Surgery. 2001. Vol. 129, №5. P. 633-640. doi:10.1067/msy.2001.113375

[39] Dianliang Z, Jieshou L, Zhiwei J, et al. Association of plasma levels of tumor necrosis factor (TNF)-α and its soluble receptors, two polymorphisms of the TNF gene, with acute severe pancreatitis and early septic shock due to it. Pancreas. 2003;26(4):339-43. doi:10.1097/00006676-200305000-00005

[40] Kavutharapu S., Nagalla B., Abbagani V., et al. Role of Proteases and Antiprotease in the Etiology of Chronic Pancreatitis // Saudi Journal of Gastroenterology. 2012. Vol. 18, №6. P. 364-368. doi:10.4103/1319-3767.103427

[41] Powell JJ, Fearon KC, Siriwardena AK, et al. Evidence against a role for polymorphisms at tumor necrosis factor, interleukin-1 and interleukin-1 receptor antagonist gene loci in the regulation of disease severity in acute pancreatitis. Surgery. 2001;129 (5):633-40. doi:10.1067/msy.2001.113375

[42] Александрович Ю.С., Гордеев В.И. Оценочные и прогностические шкалы в медицине критических состояний. СПб.: ООО «Медкнига «ЭЛБИ»; 2007.

[43] Kavutharapu S, Nagalla B, Abbagani V, et al. Role of Proteases and Antiprotease in the Etiology of Chronic Pancreatitis. Saudi Journal of Gastroenterology. 2012;18(6):364-8. doi:10.4103/1319-3767.103427

[44] Баранов B.C. Полиморфизм генов, экогенетические болезни и предикативная персонализированная медицина // Экологическая генетика. 2011. Т. 9, №3. С. 3-14.

[45] Aleksandrovich YuS, Gordeyev VI. Otsenochnyye i prognosticheskiye shkaly v meditsine kriticheskikh sostoyaniy. Saint-Petersburg: LLC «Medkniga «ELBI»; 2007. (In Russ).

[46] Корниенко Е.А., Ягупова А.А. Современные представления об этиологии хронического панкреатита и коррекции функциональной недостаточности поджелудочной железы // Вопросы современной педиатрии. 2012. Т. 11, №4. С. 134-138.

[47] Baranov VS. Gene polymorphism, ecogenetic diseases and predictive personalized medicine. Ecological Genetics. 2011;9(3):3-14. (In Russ).

[48] Raphael K.L., Willingham F.F. Hereditary pancreatitis: current perspectives // Clinical and Experimental Gastroenterology. 2016. №9. P. 197-207. doi:10.2147/CEG.S84358

[49] Korniyenko EA, Yagupova AA. Modern views on etiology of chronic pancreatitis and correction of functional insufficiency of the pancreas. Current Pediatrics. 2012;11(4):134-8.(In Russ).

[50] Whitcomb D.C. Framework for interpretation of genetic variations in pancreatitis patients // Frontiers in Physiology. 2012. №3. P. 440. doi:10.3389/fphys.2012.00440

[51] Raphael KL, Willingham FF. Hereditary pancreatitis: current perspectives. Clinical and Experimental Gastroenterology. 2016;(9):197-207. doi:10.2147/CEG.S84358

[52] Xiao Y., Yuan W., Yu B., et al. Targeted Gene Next-Generation Sequencing in Chinese Children with Chronic Pancreatitis and Acute Recurrent Pancreatitis // The Journal of Pediatrics. 2017. Vol. 191. P. 158-163. doi:10.1016/j.jpeds.2017.08.063

[53] Whitcomb DC. Framework for interpretation of genetic variations in pancreatitis patients. Frontiers in Physiology. 2012;(3):440. doi:10.3389/fphys.2012.00440

[54] Аульченко Ю.С., Аксенович Т.И. Методологические подходы и стратегии картирования генов, контролирующих комплексные признаки человека // Информационный Вестник ВОГиС. 2006. T. 10, №1. С. 189-202.

[55] Xiao Y, Yuan W, Yu B, et al. Targeted Gene Next-Generation Sequencing in Chinese Children with Chronic Pancreatitis and Acute Recurrent Pancreatitis. The Journal of Pediatrics. 2017;191:158-63. doi:10.1016/j.jpeds.2017.08.063

[56] Маркова Е.В. Зотова Н.В., Титова Н.М., и др. Значение полиморфизма генов PRSS1, GSTM1 и GSTT1 при остром панкреатите // Медицинская Генетика. 2004. №8. С. 388-391.

[57] Aulchenko YuS, Axenovich TI. Methodological approaches and strategies for mapping genes controlling complex human traits. The Herald of Vavilov Society of Geneticists and Breeding Scientists. 2006;10(1):189-202. (In Russ).

[58] Bemardino A.L.F., Guarita D.R., Carlos B.M., et al. CFTR, PRSS1 and SPINK1 Mutations in the Development of Pancreatitis in Brazilian Patients // JOP: Journal of the Pancreas. 2003. Vol. 4, №5. Р. 169-177.

[59] Markova EV Zotova NV, Titova NM, et al. Znacheniye polimorfizma genov PRSS1, GSTM1 i GSTT1 pri ostrom pankreatite. Meditsinskaya Genetika. 2004;(8):388-91. (In Russ).

[60] Gasiorowska A., Talar-Wojnarowska R., Czupryniak L., et al. The Prevalence of Cationic Trypsinogen (PRSS1) and Serine Protease Inhibitor Kazal Type 1 (SPINK1) Gene Mutations in Polish Patients with Alcoholic and Idiopathic Chronic Pancreatitis // Digestive Diseases and Sciences. 2011. Vol. 56, №3. P. 894-901. doi:10.1007/s10620-010-1349-4

[61] Bemardino ALF, Guarita DR, Carlos BM, et al. CFTR, PRSS1 and SPINK1 Mutations in the Development of Pancreatitis in Brazilian Patients. JOP: Journal of the Pancreas. 2003;4(5):169-77.

[62] Sargen K., Demaine A.G., Kingsnorth A.N. Cytokine Gene Polymorphisms in Acute Pancreatitis // JOP: Journal of the Pancreas. 2000. Vol. 1, №2. P. 24-35. doi:10.6092/1590-8577/423

[63] Gasiorowska A, Talar-Wojnarowska R, Czupryniak L, et al. The Prevalence of Cationic Trypsinogen (PRSS1) and Serine Protease Inhibitor Kazal Type 1 (SPINK1) Gene Mutations in Polish Patients with Alcoholic and Idiopathic Chronic Pancreatitis. Digestive Diseases and Sciences. 2011;56(3):894-901. doi:10.1007/s10620-010-1349-4

[64] Simon P., Weiss F.U., Sahin-Tóth M., et al. Hereditary pancreatitis caused by a novel PRSS1 mutation (Arg-122->Cys) that alters autoactivation and autodegradation of cationic trypsinogen // The Journal of Biological Chemistry. 2001. Vol. 277, №7. P. 5404-5410. doi:10.1074/jbc.M108073200

[65] Sargen K, Demaine AG, Kingsnorth AN. Cytokine Gene Polymorphisms in Acute Pancreatitis. JOP: Journal of the Pancreas. 2000;1(2):24-35. doi:10.6092/1590-8577/423

[66] Zou W.B., Tang X.Y., Zhou D.Z., et al. SPINK1, PRSS1, CTRC, and CFTR Genotypes Influence Disease Onset and Clinical Outcomes in Chronic Pancreatitis // Clinical and Translational Gastroenterology. 2018. Vol. 9, №11. P. 204. doi:10.1038/s41424-018-0069-5

[67] Simon P, Weiss FU, Sahin-Tóth M, et al. Hereditary pancreatitis caused by a novel PRSS1 mutation (Arg-122->Cys) that alters autoactivation and autodegradation of cationic trypsinogen. The Journal of Biological Chemistry. 2002;277(7):5404-10. doi:10.1074/jbc.M108073200

[68] Chang Y.T., Chang M.C., Su T.C., et al. Association of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) muta-tion/variant/haplotype and Tumor Necrosis Factor (TNF) Promoter Polymorphism in Hyperlipidemic Pancreatitis // Clinical Chemistry. 2008. Vol. 54, №1. P. 131-138. doi:10. 1373/clinchem.2007.093492

[69] Zou W-B, Tang X-Y, Zhou D-Z, et al. SPINK1, PRSS1, CTRC, and CFTR Genotypes Influence Disease Onset and Clinical Outcomes in Chronic Pancreatitis. Clinical and Translational Gastroenterology. 2018;9(11):204. doi:10.1038/s41424-018-0069-5

[70] Губергриц Н.Б., Кишеня М.С., Голубова О.А. Полиморфизм генов метаболизма этанола при хроническом алкогольном панкреатите // Терапевтический архив. 2014. №2. С. 49-55.

[71] Chang Y-T, Chang M-C, Su T-C, et al. Association of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) mutation/variant/haplotype and Tumor Necrosis Factor (TNF) Promoter Poly-Morphism in Hyperlipidemic Pancreatitis. Clinical Chemistry. 2008;54(1):131-8. doi:10.1373/clinchem.2007.093492

[72] Averbuch L.D., Mavilia M.G. SPINK-1 Polymorphism as a Pancreatitis Risk Factor // Cureus. 2019. Vol. 11, №1. P. e3852. doi:10.7759/cureus.3852

[73] Gubergrits NB, Kishenia MS, Golubova OA. Polymorphism of ethanol metabolism genes in alcoholic chronic pancreatitis. Terapevticheskii Arkhiv. 2014; (2):49-55. (In Russ).

[74] Вайсерман А., Ржешевский А. Эпигенетика: мутации без изменения ДНК // Популярная механика. 2015. №148. С. 30-34.

[75] Averbuch LD, Mavilia MG. SPINK-1 Polymorphism as a Pancreatitis Risk Factor. Cureus. 2019; 11(1):e3852. doi:10.7759/cureus.3852

[76] Ванюшин Б.Ф. Эпигенетика сегодня и завтра // Вавиловский журнал генетики и селекции. 2013. Т. 17, №4-2. С. 805-832.

[77] Vayserman A, Rzheshevskiy A. Epigenetika: mutatsii bez izmeneniya DNK. Populyarnaya Mekhanika. 2015;(148):30-4. (In Russ).

[78] Горбунова В.Н. Генетика и эпигенетика синтропных заболеваний // Экологическая генетика. 2010. Т. 8, №4. С. 39-43.

[79] Vanyushin BF. Epigenetics today and tomorrow. Vavilov Journal of Genetics and Breeding. 2013;17(4-2):805-32. (In Russ).

[80] Sandoval J., Pereda J., Pérez S., et al. Epigenetic Regulation of Early and Late-Response Genes in Acute Pancreatitis // Journal of Immunology. 2016. Vol. 197, №10. P. 4137-4150. doi:10.4049/ jimmunol.1502378

[81] Gorbunova VN. Genetics and epigenetics of syntropic diseases. Ecological Genetics. 2010;7(4): 39-43. (In Russ).

[82] Mehmood R., Varga G., Mohanty S.Q., et al. Epi-genetic reprogramming in Mist1(-/-) mice predicts the molecular response to cerulein-induced pancreatitis // PLoS One. 2014. Vol. 9, №1. P. e84182. doi:10.1371/journal.pone.0084182

[83] Sandoval J, Pereda J, Pérez S, et al. Epigenetic Regulation of Early- and Late-Response Genes in Acute Pancreatitis. Journal of Immunology. 2016; 197(10):4137-50. doi:10.4049/jimmunol.1502378

[84] Negoi I., Beuran M., Hostiuc S., et al. Glycosylation alterations in acute pancreatitis and pancreatic cancer: CA19-9 expression is involved in pathogenesis and maybe targeted by therapy // Annals of Translational Medicine. 2019. Vol. 7,№8. P. S306. doi:10.21037/atm.2019.10.72

[85] Mehmood R, Varga G, Mohanty SQ, et al. Epigenetic reprogramming in Mist1(-/-) mice predicts the molecular response to cerulein-induced pancreatitis. PLoS One. 2014;9(1):e84182. doi:10.1371/journal.pone.0084182

[86] Natale F., Vivo M., Falco G., et al. Deciphering DNA methylation signatures of pancreatic cancer and pancreatitis// Clinical Epigenetics. 2019. Vol. 11, №1. P. 132. doi:10.1186/s13148-019-0728-8

[87] Negoi I, Beuran M, Hostiuc S, et al. Glycosylation alterations in acute pancreatitis and pancreatic cancer: CA19-9 expression is involved in pathogenesis and maybe targeted by therapy. Annals of Translational Medicine. 2019;7(8):S306. doi:10.21037/atm.2019.10.72

[88] Bloomston M., Frankel W.L., Petrocca F., et al. MicroRNA Expression Patterns to Differentiate Pancreatic Adenocarcinoma From Normal Pancreas and Chronic Pancreatitis // JAMA. 2007. Vol. 297, №17. P. 1901-1908. doi:10.1001/jama.297.17.1901

[89] Natale F, Vivo M, Falco G, et al. Deciphering DNA methylation signatures of pancreatic cancer and pancreatitis. Clinical Epigenetics. 2019;11(1): 132. doi:10.1186/s13148-019-0728-8

[90] Шахтарин В.В. Результаты исследования геномных ассоциаций (Genome Wide Association Studies) – в эндокринологическую практику // РМЖ. 2012. №3. C. 133.

[91] Bloomston M, Frankel WL, Petrocca F, et al. MicroRNA Expression Patterns to Differentiate Pancreatic Adenocarcinoma From Normal Pancreas and Chronic Pancreatitis. JAMA. 2007. 297(17): 1901-8. doi:10.1001 /jama.297.17.1901

[92] Giri A.K., Midha S., Banerjee P., et al. Common Variants in CLDN2 and MORC4 Genes Confer Disease Susceptibility in Patients with Chronic Pancreatitis // PLoS ONE. 2016. Vol. 11, №1. P. e0147345. doi:10.1371/journal.pone.0147345

[93] Shakhtarin VV. Rezul’taty issledovaniya genomnykh assotsiatsiy (Genome Wide Association Studies) – v endokrinologicheskuyu praktiku. Russian Medical Journal. 2012;(3):133. (In Russ).

[94] Giri AK, Midha S, Banerjee P, et al. Common Variants in CLDN2 and MORC4 Genes Confer Disease Susceptibility in Patients with Chronic Pancreatitis. PLoS ONE. 2016;11(1):e0147345. doi:10.1371/ journal.pone.0147345

RIGHTS & PERMISSIONS

Eco-Vector